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I F.% 
, ABSTRACT. Objective. To assess the effects of contin- f ued feeding of nonhuman milks or formulas to young 
children during acute diarrhea on their treatment failure t rates, stool frequency and amount, diarrheal duration, and 1 change in body weight. 
Methods. A total of 29 randomized clinical trials of 
2215 patients were identified by computerized biblio- 
graphic search and review of published articles. Data 
were abstracted and analyzed using standard meta- 
Results. Among studies that compared lactose- 
containing milk or formula diets with lactose-free regi- 
mens, those children who received the lactose-containing 
diets during acute diarrhea were twice as likely to have a 
treatment failure as those who received a lactose-free diet 
(22% vs 12%, respectively; P < ,001). However, the excess 
treatment failure rates occurred only in those studies that 
included patients whose initial degree of dehydration, as 
reported by authors, was severe, or that were conducted 
before 1985, when appropriate diarrhea treatment proto- 
cols were first widely accepted. Among studies of patients 
with mild diarrhea, all but one of whicX were completed 
after 1985, the overall treatment failure rates in the lactose 
groups were similar to the rates in the lactose-free groups 
(13% vs 15%). These results suggest that children with 
mild or no dehydration and those who are managed ac- 
cording to appropriate treatment protocols, such as that 
promoted by the World Health Organization, can be 
treated as successfully with lactose-containing diets as 
with lactose-free ones. The pooled information from stud- 
ies that compared undiluted lactose-containing milks 
with the same milks offered at reduced concentration con- 
cluded that (1) children who received undiluted milks 
were marginally more likely to experience treatment fail- 
ure than those who received diluted milk (16% vs 12%, 
P = .05), (2) the differences in stool output were small and 
of limited clinical importance, and (3) children who re- 
ceived the undiluted milk diets gained 0.25 SD more 
weight than those who received the diluted ones ( P  = 
.004). In addition, as with the previous set of studies, there 
were no differences in the pooled treatment failure rates 
between the respective groups in those studies of mildly 
dehydrated patients conducted after 1985 (14% vs 12%). 
Conclusions. The vast majority of young children with 
acute diarrhea can be successfully managed with contin- 
ued feeding of undiluted nonhuman milks. Routine di- 
lution of milk and routine use of lactose-free milk formula 
are therefore not necessary, especially when oral rehydra- 
: analytic procedures. 
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tion therapy and early feeding (in addition to milk) form 
the basic approach to the clinical management of diarrhea 
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The appropriate use of lactose-containing, nonhu- 
man milks for young children with acute diarrhea is 
frequently debated. Whereas some clinicians rou- 
tinely withdraw milk from the diets of children dur- 
ing diarrhea, primarily to avoid the potential conse- 
quences of lactose malabsorption, others continue to 
offer milk without apparent evidence of increased 
clinical complications. We have recently summarized 
background information on the rationales for each ap- 
proach to therapy'T2 and have presented descriptive 
reviews of published trials of dietary regimens con- 
taining varied amounts of milk and other dairy 
products." 
Notably, one of these reviews discovered that much 
of the difference in the results of the previous studies 
could be attributed to the nature of the comparison 
diet empl~yed .~  In particular, when diets including 
milk were compared with either milk-free regimens 
or with lactose-free milk products, children who re- 
ceived lactose-containing milks tended to have 
greater severity and duration of diarrhea and higher 
rates of clinical complications. 
By contrast, when milk-containing diets were com- 
pared with other milk-based regimens that were ei- 
ther more dilute or introduced later during the course 
of therapy, there was little apparent difference be- 
tween the treatment groups. It was concluded that 
although the majority of children can safely continue 
consuming diets based on nonhuman milks during 
diarrhea, "complications of milk feeding. . . will occur 
in a sizable sub-group of  patient^."^ 
To explore these issues further, we have completed 
a quantitative meta-analysis of available clinical trials. 
In one set of analyses, diarrhea outcome variables 
were compared for children treated with either 
lactose-containing milks or lactose-free products. In 
the second set of analyses, these same outcomes were 
studied for children who received either undiluted 
lactose-containing milk or the same product in either 
more dilute form or introduced later during hospi- 
talization. The results of these meta-analyses are re- 
ported herein. 
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J METHODS 
*r 
Identification and Selection of Studies 
Published references were identified using the Medline com- 
puterized bibliographic database and the following key words: 
diarrhea, gastroenteritis, milk, milk intolerance, lactose malab- 
sorption, lactose intolerance, nutrition, and dietary therapy. Ad- 
ditional studies were located from citations in these references, 
other bibliographic sources, and key informants working in this 
field. Except for two unpublished references, which were obtained 
from the Diarrhoeal Disease Control Programme of the World 
Health Organization (WHO), only published reports were consid- 
ered in an attempt to ensure the quality of the research. The 
exceptions were allowed because the studies were closely moni- 
tored by WHO personnel. Other criteria for inclusion of individual 
studies were that (1) they were randomized clinical trials, (2) they 
reported at least one of the major outcome variables of interest, 
and (3) the study diets were compatible with the group assign- 
ments described above. Because the published reports generally 
provided limited information on the randomization techniques, 
we could not assess the validity of these procedures in the most 
cases. Studies of milk added to mixed diets were excluded unless 
milk was the predominant energy source, and studies of yogurt 
and of human milk were also eliminated. Projects that specifically 
included only children with persistent diarrhea were also ex- 
cluded, although some of the accepted reports may have con- 
tained some patients with persistent illness. A total of 29 studies of 
2215 patients were included in the final analyses.M3 All but two 
 tud di es'^*'^ included only hospitalized patients. The children‘s ages 
ranged from O to 59 months, although most studies included chil- 
dren younger than 36 months of age. 
Summary of Outcome Variables and Statistical 
Analyses 
Once a study was considered acceptable for inclusion, the ma- 
jor outcome variables were summarized in tabular form, sepa- 
rately for studies of lactose-containing vs non-lactose-containing 
diets and for studies of undiluted milk vs diluted or delayed 
introduction of milk. The data were summarized independently 
by two of the coauthors and any discrepancies were rectified. One 
study,” which included dietary groups permitting both sets of 
comparisons, was used twice. In several other studies in which 
more than two diets were compared, the groups that conformed 
most closely to the specific dietary hypothesis of interest were 
usually selected. However, in two  tud di es'^,'^ in which a lactose- 
containing formula was compared with several non-lactose-con- 
taining formulas, data from the latter groups were combined. 
When undiluted milk was compared with more than one dilution 
of milk, the group with the most extreme dilution was included in 
the analysis. 
Outcome variables of interest included rates of treatment fail- 
ures, stool frequency or amount, duration of diarrhea, and change 
in body weight. Treatment failures were defined in various ways 
by the different investigators, usually on the basis of increasing 
diarrheal severity or persistence of diarrhea or recurrence of de- 
hydration. In some cases14*16J426B no specific information on treat- 
ment failures was presented, but the limited severity of the pa- 
tients’ disease in these particular studies and the authors’ 
implications that all were discharged from the study in timely 
fashion led us to conclude that no treatment failures had occurred. 
When stool output data were presented separately for several 
days of treatment, we used the data for earlier days (when diar- 
rhea was presumably more severe and the differences between the 
diets were usually greater) preferentially. When information on 
duration of diarrhea was not specified, but the authors stated that 
the patients were discharged from hospital when the diarrhea 
improved, we used the data for duration of hospitalization in- 
~ t e a d . 2 ~ * ~ 3 ~ 3  We also attempted to compare change in body 
weight as a result of dietary therapy during the studies, although 
the extensive variability in expression of this information and in 
the duration of follow-up measurements may have limited the 
usefulness of these analyses. The changes in body weight were 
monitored for periods ranging from 1 to 7 days; in s ix  studies this 
increment was recorded for variable lengths of time between ad- 
mission and discharge. 
For each of the variables, the data from individual studies were 
compared separately and the combined results from all studies 
were also pooled together in a single comparison. The hypothesis 
of no treatment effect was assessed with the Stouffer’s combined 
test, which is calculated by summing the z scores associated with 
the P values from the individual studies, and dividing by the 
square root of the number of studies, and which has a standard 
normal distribution under the null hypothesis.= When statistically 
significant differences were identified by treatment category, the 
magnitude of the effect of dietary treatment on the outcome of 
interest was then estimated for each individual study by dividing 
the difference between the means by the pooled standard devia- 
tion. For continuous variables, the average effect size was esti- 
mated using a weighted mean of the individual effect sizes, and 
homogeneity of effect sizes was tested using a weighted sum of 
squared deviations from the mean effect size?5 which has a y 
distribution under the null hypothesis that the effect sizes are 
equal. Significant heterogeneity suggests that the individual stud- 
ies were not similar enough to be compared in the same meta- 
analysis. When the effect sizes were nonhomogeneous, individual 
studies were reexplored to determine whether differences in study 
design or subjects might explain the extreme values. For treatment 
failure rates, the overall relative risk and its confidence interval 
were calculated from the logit estimator?6 Because no tests for 
homogeneity of relative risks were readily available, the Breslow- 
Day test of homogeneity of odds ratios was used as a proxy for 
relative risks to assess whether they differed between studies?6 All 
calculations were done with PC-SAS Release 6.04. 
RESULTS 
Studies of Lactose-Containing Versus Non-Lactose- 
Containing Diets 
Fourteen studies were identified and considered 
acceptable for inclusion in this Of these, 
three were unusual because they compared lactose- 
containing milk with lactase-treated, low-lactose 
milk12 or compared milk with a mixture of either rice, 
beans, sugar, and oiP5 or plantain, chicken, and 0i1.l~ 
All of the remaining studies compared (1) a milk for- 
mula with a lactose-free soy formula, (2) a lactose- 
containing soy formula with a lactose-free soy for- 
mula,’3 (3) a lactose-containing milk formula with a 
lactose-free xnilk protein formula,’0J6 or (4) some com- 
bination of these diets. 
Two of the studies deserve special mention because 
of the somewhat unusual characteristics of the pa- 
tients included. Rajah et allo enrolled only those pa- 
tients who had previously had more than 48 hours of 
diarrhea in hospital, still “required intravenous fluid 
to maintain hydration,” and excreted more than 30 
g/kg of stool per day. Rothman et all6 only admitted 
patients with kwashiorkor and diarrhea. Because of 
the atypical nature of these subjects, the meta- 
analyses were conducted both with and without these 
two studies. 
Treatment Failure Rates 
Of the 14 studies identified, only one18 did not pro- 
vide information on treatment outcomes (Table l). As 
indicated above, the criteria for treatment failures var- 
ied considerably among studies; but the authors’ defi- 
nitions, as summarized in Table 2, were accepted in 
all cases, even when they were not supported by ob- 
jective clinical evidence. The treatment failure rates 
were sigruficantly greater among children receiving 
the lactose-containing diets than among those receiv- 
ing lactose-free diets in 6 of the 13 studies. There were 
no significant differences by dietary group in the re- 
maining studies. Overall, 22% (95% confidence inter- 
val [CI] = 18%, 27%) of children who consumed lac- 
IS NONHUMAN MILK AND ACUTE DIARRHEA 
1 TABLE 1. 
Lactose-Free diets 
Treatment Failure Rates of Diarrhea Patients Receiving Either Lactose-Containing or 
Study Dietary Group Significance* 
Lactose Nonlactose 
No. of % No. of % 
Patients Failures Patients Failures 
Suttonì 49 40.8 48 8.3 <.o01 
Gabr' 29 51.7 29 13.8 .o02 
Naidoo9 56 25.0 56 7.1 .o10 
Rajah'" 16 81.2 56 44.6 ,010 
Conway" 50 8.0 50 8.0 1.000 
Brown12 28 14.3 30 20.0 .732 
GroothiusI3 19 5.3 59 6.8 .814 
I s o l a ~ r i ~ ~  38 O 27 O 1.000 
BhanI5 29 3.4 28 7.1 .532 
RothmanI6 6 O 6 O 1.000 
Romer" 33 15.2 34 5.9 .259 
Pooled data 399 22.3 474 11.8 <.o001 
Leake6 11 63.6 11 9.1 .O08 
Dagans 35 14.3 40 O .O19 
* P value, ,$ analyses, or Fisher exact test. 
TABLE 2. 
Rates When Lactose-Containing and Lactose-Free Diets Were Compared 
of Study (Year) Rx Failure* Illnesst 
Characteristics of Studies That Did or Did Not Find Differences in Treatment Failure 
Conclusions Study Criteria for Severity of Type of "Milk"$ 
Increased treatment Suttons (1968) 
failure Leake6 (1974) 
Gabr' (1979) 
Dagans (1984) 
Naidoog (1981) 
Rajah'" (1988) 
BrownI2 (1991) 
GroothiusI3 (1986) 
Isolauri'" (1986) 
Bhan'j (1988) 
RothmanI6 (1980) 
Romer" (1991) 
No difference Conway" (1989) 
~~ ~ 
Mild/severe-B 
Severe-B 
Mod/severe-A 
Mod/severe-A 
Severe-B 
Severe-A 
Mild-A 
Mild / Mod-A 
Mild-A (outpatient) 
Mild/Mod-A 
Mild-A (outpatient) 
? 
Mild/Mod-A 
~ ~~ 
SF + lactose 
Skim milk 
MF 
Cow milk + Glu 
Cow milk 
MF 
MF 
MF 
SF -!- lactose 
MF or cow milk 
MF 
Cow milk 
Cow milk 
* Criteria for treatment failure: F, stool frequency or amount either worsening or greater than cutoff; 
D, duration of symptoms of diarrhea, vomiting, and/or dehydration greater than cutoff; R, recurrence 
of diarrhea and/or dehydration; W, weight loss; I, evidence of lactose intolerance. 
t Degree of dehydration or "need for" fasting or intravenous solution, as reported by author. Mod, 
moderate; A, hydration status assessed by clinical signs; B, author's report of severity only. 
$ SF, soy formula; MF, milk formula. 
tose were therapeutic failures compared with 12% 
(95% CI = 9%, 15%) of those who did not receive 
lactose ( P  < .0001). 
The data on outcome of therapy were also analyzed 
as relative risks (RRs) for treatment failure (Fig 1). 
Children who received lactose in their diets had 
RRs of treatment failure that ranged from 0.5 to 7.0 
in the different studies compared with those who 
did not receive lactose. The pooled RR was 2.1 (95% 
CI = 1.6,2.7), which was significantly greater than 1.0 
( P  < .0001). However, the Breslow-Day test showed 
significant heterogeneity of odds ratios (P = .016). 
When the studies by Rajah et all0 and Rothman et all6 
were excluded from the analyses, the results were 
similar, with overall treatment failure rates of 20% 
with lactose and 7% with nonlactose diets ( P  < .0001) 
and a pooled RR of 2.4 (95% CI = 1.6, 3.7). There 
was still significant heterogeneity of these results 
( P  = .012). 
Because of the heterogeneity of findings concerning 
treatment failure rates, we completed a second set of 
analyses to explore factors that may have explained 
the different results among studies. We considered 
the initial severity of diarrhea or dehydration (as re- 
ported by the authors), the criteria used to define 
treatment failures, and the type of milk used. These 
factors were compared for those studies that found 
either significantly different or similar outcomes of 
therapy (Table 2). In general, those studies that found 
increased rates of treatment failure among patients 
who received lactose-containing diets were those that 
included patients whose initial degree of dehydra- 
tion, as reported by the authors, was severe. This clas- 
sification of hydration status must, however, be 
accepted with considerable caution because, as men- 
tioned earlier, the authors' reports of initial severity 
of dehydration were not always supported by objec- 
tive clinical evidence. Among those studies that in- 
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Fig 1. Relative risk of treatment failure with lactose-containing 
diet vs lactose-free diet, by initial severity of dehydration. 
eluded patients with apparently severe dehydration 
initially, 38% (95% CI = 31%, 44%) of children became 
treatment failures with lactose compared with 16% 
(95% CI = 12%, 20%) who became treatment failures 
in the nonlactose groups (P < .OOOl). The RR of treat- 
ment failure with the lactose-containing diets was 2.4 
(95% CI = 1.8,3.3). The results of the test for hetero- 
geneity were no longer statistically significant (P = 
.80). By contrast, when we examined the studies that 
included only patients with less severe dehydration, 
the treatment failure rates in the lactose groups (7%; 
95% CI = 5%, 12%) were similar to those in the non- 
lactose groups (8%; 95% CI = 5%, 12%; P = .94). The 
RR of 1.0 (95% CI = 0.5, 1.9) was not significantly 
different from 1.0. Again, the results of the test for 
heterogeneity were nonsignificant (P = .68). 
In addition to the apparent relationship between 
the initial severity of illness and treatment outcome, 
we discovered during this secondary analysis that all 
but one of the studies that detected higher rates of 
treatment failure with lactose-containing diets were 
conducted before the mid-198Os, when standardized 
diarrhea treatment protocoIs, including rapid correc- 
tion of dehydration with oral rehydration salts solu- 
tion and continued feeding, were first widely ac- 
cepted. The one study reporting higher treatment 
failure rate with the lactose-containing diet, and con- 
ducted after 1985, included only patients with previ- 
ous treatment faihu-e.*0 By contrast, all but one of the 
studies that reported no differences in treatment out- 
comes by type of dietary therapy were completed 
after 1985. When the studies published before 1986 are 
considered, the rates of treatment failure were 33% 
(95% CI = 27%, 38%) with lactose-containing diets 
and 7% (95% CI = 4%, 10%) with lactose-free diets 
(P < .OOOl>. The RR of treatment failure with lactose 
was 4.4 (95% CI = 2.5,7.6), and the results of the test 
for homogeneity were nonsignificant (P = .70). 
Among studies completed after that date the overall 
treatment failure rate of 13% (95% CI = 9%, 17%) in 
the lactose groups was similar to the rate of 15% (95% 
CI = 12%, 19%) in the comparison groups. 
Studies that reported increased failure rates in the 
lactose group also tended to apply criteria such as 
greater stool frequency or increased duration of 
symptoms to define treatment failure, whereas the 
other studies tended to rely on more stringent evi- 
dence of failure such as recurrent dehydration or 
weight loss, which are probably of greater clinical rel- 
evance. Interestingly, the type of milk used did not 
seem to explain the different findings of these two sets 
of studies. 
In summary, the heterogeneity of results that was 
observed when all studies were analyzed together 
may have been due to (1) differences in the patients’ 
initial severity of dehydration, (2) the year of the 
study and approach to management, or (3) the criteria 
used to define treatment failure. Regardless of which 
explanation is most important, we conclude that non- 
dehydrated children can be managed as successfully 
with lactose-containing diets as with lactose-free regi- 
mens. Moreover, results of studies completed since 
1985 suggest that children who are managed accord- 
ing to standardized treatment protocols, such as that 
promoted by WHO, can be managed as successfully 
with lactose-containing diets as with lactose-free ones 
regardless of their initial hydration status, although 
the results of one studylo suggest that children who 
experience one treatment faihrre while receiving milk 
may be more likely to have a second if treated con- 
tinuously with a lactose-containing diet. 
Stool Frequency and Stool Amount 
Only four of the reports provided information on 
stool frequency and four on stool amount. In all cases 
the stool frequencies were greater in the groups re- 
ceiving Iactose (Table 3), although these’ differences 
were statistically significant in just one study.5 The 
TABLE 3. Stool Frequency (No. of Bowel Movements per Day) During Hospitalization of Diar- 
rhea Patients Receiving Either Lactose-Containing or Lactose-Free Diets 
Study Dietary Group d* P 
Lactose Nonlactose 
Mean 2 SD n Mean & SD n 
Sutton5 5.0 2 3.5 49 2.2 h 2.8 48 0.882 c.001 
Naidoog 4.5 t 3.3 56 4.2 C 3.0 56 0.095 .616 
Conway” 1.8 t 1.5 50 1.6 t 1.7 50 0.125 53-s 
Groothius” 5.9 + 1.9 19 5.6 2 2.0 59 0.152 .567 
Pooled data 4.0 Ic- 3.2 174 3.5 t 2.9 213 0.298 .004 
* d = the standardized difference between treatment groups, calculated as 
(2, - &,)/SDP, where X, = mean value for lactose group, 
x,, = mean value for nonlactose group, and 
SD, = pooled SD of both groups. 
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pooled results showed a statistically significant dif- 
ference between groups ( P  = .004). However, there 
was significant heterogeneity of these study results 
(P = .OZ), and the pooled differences could be ex- 
plained entirely by the results of one study? Notably, 
during the first day of this latter study, 10% sugar 
solutions containing either lactose or glucose were ad- 
ministered to the groups that received these respec- 
tive sugars in their soy-based formula. It is likely that 
the high initial levels of sugar intake contributed to 
the excessive difference in stool frequency that was 
observed. When this study was removed from the 
analysis, the likelihood of rejecting the null hypoth- 
esis was no longer statistically signrficant (P = .33). 
Even when this study is included, however, the mag- 
nitude of the differences in stool frequency (0.30 SD 
or 0.2 to 2.8 bowel movements per day) is of minor 
clinical importance. 
Four of the papers presented quantitative informa- 
tion on stool outputs (Table 4). The combined results 
indicated that there were significantly greater stool 
outputs by children in the lactose groups (P = .005), 
with differences between groups ranging from -132 
to 165 g/d, an average effect size of 0.42 SD. However, 
the presence of significant (P = .003) heterogeneity of 
these results complicates the interpretation. Notably, 
the study that reported lower stool volumes with the 
lactose-containing diet employed an atypical design 
in which lactose-containing milk was compared with 
lactose-hydrolyzed milk. The osmolality of the latter 
formula was considerably greater than that of the 
nontreated milk, possibly overriding the ability to 
detect any negative effect of intact lactose. On the 
other hand, the two studies that reported signifi- 
cantly greater stool outputs with lactose enrolled 
patients with either severe malnutrition or with pre- 
vious treatment failure.10*16 Thus, excess stool vol- 
ume may occur in response to lactose feeding only 
among this subgroup of patients. Considering the 
results pertaining to both indicators of diarrheal se- 
verity (ie, stool frequency and amount), it appears 
that the lactose-containing milks or formulas caused 
marginally greater stool outputs than the lactose- 
free ones, although these differences are unlikely to 
be of clinical importance except possibly among 
children with previous treatment failures or severe 
underlying malnutrition. \ 
Duration of Diarrhea 
Nine studies reported data on the duration of di- 
arrhea following initiation of therapy (Table 5). The 
pooled results indicated that there was a small, but 
statistically significant, increase in mean diarrheal du- 
ration which ranged from -85 to 67 hours in the dif- 
ferent studies when lactose-containing milk was con- 
sumed (P = .OOl>. The average size of this effect 
amounted to 0.22 SD. 
There was significant heterogeneity of the magni- 
tude of difference in diarrheal duration by study 
group (P < .001). Three of the eight studies of diar- 
rheal duration, including two of those in which the 
durations were longer in the nonlactose groups, per- 
mitted the patients to receive solid foods in addition 
to the milk formula diets."J4J5 Because of the poten- 
tially dramatic effect of additional foods on the du- 
ration of liquid stool excre t i~n , '~ ,~~t~~ these other foods 
may have prevented the detection of any effect of lac- 
tose. When the data were reanalyzed excluding these 
three studies, the mean f SD diarrheal duration was 
greater in the lactose groups than in the nonlactose 
groups (95 & 69 hours vs 82 & 53 hours, P < .001), 
although the effect sizes (average = 0.295 SD) were 
still nonhomogeneous (P .001). Thus, it seems likely 
that inclusion of lactose-containing products in diets 
composed exclusively of milk or infant formulas in- 
creased the duration of diarrhea, but the results are 
not consistent across all studies. When other solid 
foods are provided in addition to milk, the inclusion 
of lactose in the mixed diet does not appear to affect 
the duration of illness. 
Weight Gain 
Only four ~tUdies '~~'~~'~~' '  presented data on change 
in body weight during therapy. Of these,  WO^^,^^ al- 
lowed other foods in addition to the study diets. The 
results were extremely variable, both within and be- 
tween studies, and none of the differences by dietary 
group was statistically signrficant. Because of the 
small number of studies that reported this informa- 
tion and because of the use of other foods, we do not 
TABLE 4. 
Hospitalization of Diarrhea Patients Receiving Either Lactose-Containing or Lactose-Free Diets 
Stool Amount (Grams per Day or Grams per Kilogram Body Weight per Day) During 
Study Dietary Group d" P 
Lactose Nonlactose 
Mean k SD n Mean t SD n 
Rajahlo 75 t 55t 16 37 k 41t 56 0.86 .O04 
Browni2 56 t 39t 28 66 t 44t 30 -0.24 .365 
Rothmani6 307 t 105t 6 142 t 61t 6 1.92 .O08 
Romeri7 147 t 105t 33 115 2 66t 34 0.37 .143 
Pooled data 83 126 0.42 .o02 
* d = the standardized difference between treatment groups, calculated as 
(x, - x,,)/SD, where -xL = mean value for lactose group, 
X,, = mean value for non-lactose group, and 
SD, = pooled SD of both groups. 
t Stool output reported as grams per day by Rothman et al and as grams per klilogram per day by 
other investigators. (No values provided for pooled data because the results were presented in 
different units.) 
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TABLE 5. 
Lactose-Containing or Lactose-Free Diets 
Duration of Diarrhea After Initiation of Study (Hours) in Patients Receiving Either 
b 
m 
Study Dietary Group d* P 
Lactose Nonlac tose 
Suttons 
DaganS 
Naidoog 
Conwayl't 
BrownI2 
Is01auri'~t 
BhanIst 
Romeri7 
HaffejeeI8 
Pooled data 
Mean 2 SD 
101 f 52 
151 C 95 
94 C 38 
68 C 44 
151 t 86 
29 2 19 
182 C 259 
76 t 50 
70 t 60 
92 2 95 
n 
49 
35 
56 
50 
28 
38 
29 
33 
120 
438 
Mean C SD 
71 t 28 
84 -C 35 
115 t 62 
51 t 42 
119 2 63 
31 t 17 
267 2 240 
56 t 49 
61 C 44 
88 t 95 
n 
48 0.72 
40 0.96 
50 0.40 
30 0.43 
56 -0.42 
27 -0.11 
28 -0.34 
34 0.40 
75 0.17 
388 0.22 
* d = the standardized difference between treatment groups, calculated as 
(x, - X,,)/SD,, where -xL = mean value for lactose group, 
X, = mean value for non-lactose group, and 
SD, = pooled SD of both groups. 
t Studies permitting other foods in addition to formula diets. 
~ 
1.001 
<.o01 
,029 
.O51 
.110 
.664 
.204 
.lo3 
.263 
.o01 
i 
believe that the effect of predominantly milk-based 
diets on weight change can be assessed reliably with 
the available information. 
Undiluted Milk Versus Diluted or Delayed Milk 
Sixteen acceptable studies were identified in which 
undiluted, lactose-containing milk was compared 
with either a reduced concentration of the same milk 
or introduction of that same milk at a later time during 
therapy."JgJ3 In all but one of these the de- 
sign called for greater dilution of milk rather than 
delayed introduction. The milks were diluted be- 
tween twofold and sixfold with water for periods of 
time ranging from 1 to 6 days or, in some cases, until 
the severity of diarrhea declined. 
Treatment Failure Rates 
ure rates (Table 6). In 3 
Fourteen studies presented data on treatment fail- 
no treatment fail- 
ures occurred in either study group. Among the 11 
groups that initially received undiluted milk ex- 
ceeded those in the comparison groups in eight cases, 
although these differences were statistically signifi- 
cant in only one. In none of the 3 studies in which the 
therapeutic failures of the diluted milk groups out- 
numbered those of the nondiluted milk groups were 
the differences statistically significant. The pooled 
treatment failure rate for undiluted milk was 16% 
(95% CI = 11%, 18%) and for diluted milk was 12% 
(95% CI = 7%, 13%; P = .05). This 4% absolute dif- 
ference between groups in the rates of treatment fail- 
ure was smaller than the effect seen when lactose- 
RR of treatment failure when the undiluted milk 
groups were compared with the diluted milk groups 
ranged from 0.5 to 7.6 (Fig 2). The combined RR for 
all studies was 1.3 (95% CI = 0.9,1.8), which was not 
remaining studies, treatment failure rates in the 1 
I 
i 
i 1 
I 
i containing and lactose-free diets were compared. The I 
< 
TABLE 6. 
Milk or the Same Milk at Reduced Concentration or Introduced Later During Therapy 
Treatment Failure Rates of Diarrhea Patients Receiving Undiluted Lactose-Containing 
Study Dietary Group Significance* 
Undiluted Diluted/Delayed 
No. of % No. of % 
Patients Failures Patients Failures 
Conway" 50 8 50 4 .400 
S o e p r a p t ~ ~ ~ t  20 5 20 10 .548 
PlaczekzOt 23 30 25 4 .O14 
Ransome*'+ 37 22 37 14 .359 
McDowellzt 47 28 46 15 .144 
ReesZ4 16 O 14 O 1.000 
MadkouPt 30 3 30 O .313 
DugdaleZ 28 25 32 9 .lo5 
ArmisteadZ7 19 26 21 19 .583 
ChiribogaZ9 38 8 37 11 .664 
C h e d o  72 19 71 20 .967 
30 43 32 41 329 
Pooled data 465 16.3 469 11.7 .O50 
PichaipaP 20 O 20 O 1.000 
Touhami28 35 O 35 O 1.000 
* P value, ,$ analyses, or Fisher exact test. 
t Studies including patients with more severe dehydration at time of admission. 
i 
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more responsible for the observed differences in the 
clinical outcomes of the different studies. 
i 9  20 21 22 25 27 29 30 11 33 
Study (Reference number) 
Fig 2. Relative risk of treatment failure with undiluted milk diet, 
by initial severity of dehydration vs diluted milk diet. 
significantly greater than 1.0. The results of the test of 
heterogeneity were nonsignificant (P = .45). 
When only studies of patients with more severe de- 
hydration initially were compared)9-22,25 the treat- 
ment failure rates with undiluted milk (20%; 95% 
CI = 15%, 25%) were greater than the rates with di- 
luted diets (9%; 95% CI = 6%, 13%; P = .003). The RR 
of treatment failure was 2.0 (95% CI = 1.2,3.3) and the 
results of the test for homogeneity were nonsignifi- 
cant ( P  = .44). When studies of patients with milder 
disease were contrasted)1,27*29,30*33 the treatment failure 
rates were 14% (95% CI = lo%, 17%) and 13% (95% 
CI = lo%, 17%), respectively (P = .69). The RR of 1.1 
(95% CI = 0.7,1.6) was not significantly different from 
1.0. Thus, any adverse effect of continued intake of 
undiluted milk on treatment outcome was limited to 
those patients with more severe illness initially. 
As with the aforementioned sets of analyses, we 
examined separately those studies conducted before 
and after 1985. The pooled treatment failure rate 
among the earlier studies was 21% (95% CI = 16%, 
26%) with undiluted milk and 10% (95% CI = 6%, 
14%) with diluted milk ( P  = .005). There were no dif- 
ferences in the pooled treatment failure rates between 
the respective groups in the later studies (14% vs 12%, 
P = .60). For the same reasons noted above, it is not 
possible to determine which of these factors, namely 
initial severity of dehydration or year of study, was 
Stool Frequency and Stool Amount 
Six of the reports contained information on stool 
frequency and three on stool amount following in- 
troduction of the study diets. Four of the former stud- 
ies found a greater number of bowel movements 
with the undiluted diet (Table 7), although only one 
of these sets of results" was statistically significant. 
One studyz9 found a slightly, but nonsignificantly, 
greater stool frequency in the diluted milk group. 
The pooled data suggest that there was a slight in- 
crease in stool frequency with continued use of un- 
diluted milk ( P  = ,046). The excess number of 
bowel movements ranged between 0.2 to 1.0 per 
day (0.18 SD). There was no significant heterogene- 
ity among study results (P = .18). 
Of the three studies that provided quantitative in- 
formation on stool outputs, t ~ o ~ ~ , ~ ~  found signifi- 
cantly higher outputs by children receiving undiluted 
mills (Table 8). The thirdB noted nearly identical ex- 
cretion rates in both groups. The pooled results from 
these three studies indicate that the adjusted stool 
outputs were significantly greater among those who 
received undiluted milk ( P  < .008), with a magnitude 
of mean difference by treatment group ranging from 
7 to 21 g/kg per day or 0.33 SD units across studies. 
The results were homogeneous across the small num- 
bers of studies examined ( P  = .47). In summary, the 
analyses of both stool frequency and stool volume 
indicate that early introduction of undiluted lactose- 
containing milk diets is associated with a slight in- 
crease in stool output compared with diluted milk, 
but these differences are probably of minor clinical 
importance. 
Duration of Diarrhea 
Ten studies provided information on diarrheal du- 
ration (Table 9). Two found significantly increased 
durations of illness with undiluted milk,28,31 and one 
reported the opposite.32 The remaining reports de- 
scribed nearly identical durations of illness in both 
dietary groups. The pooled data indicate that there 
were no significant differences by dietary group over- 
TABLE 7. Stool Frequency (No. of Bowel Movements per Day) During Hospitalization of Diar- 
rhea Patients Receiving Either Undiluted Lactose-Containing Milk or the Same Milk at Reduced 
Concentration or Introduced Later Durine Therauv 
Study Dietary Group d* P 
Undiluted Diluted/Delayed 
Mean t SD n Mean f SD n 
Conway" 1.8 ? 1.5 50 0.8 2 1.7 50 0.62 .o02 
MadkouP 11.3 2 2.3 30 11.1 C 2.5 30 0.08 .748 
PichaipaP 5.6 C 3.3 20 5.1 f 3.2 20 0.15 .629 
Chiriboga" 10 f 10 38 11 f 10 37 -0.10 .666 
Chew30 10 t 5 72 1oc5 71 O 1.000 
~0x33 4.0 t 3.0 30 3.0 C 2.3 32 0.38 .144 
Pooled data 7.3 t 6.3 240 7.0 t 6.6 240 0.18 .O46 
* d = the standardized difference between treatment groups, calculated as 
(Ru - XDD)/SD, where zu = mean value for undiluted group, 
XDD = mean value for diluted/delayed group, and 
SD, = pooled SD of both groups. 
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TABLE 8. 
Milk at Reduced Concentration or Introduced Later DuMe Therauv 
Stool Output (Grams per Day or Grams per Kilogram Body Weight per Day) During 
L1 Hospitalization of Diarrhea Patients Receiving Either Undiluted Lactose-Containing Milk or the Same 
Study Dietary Group d* P 
Undiluted Diluted / Delayed 
Mean 2 SD n Mean C SD n 
Madkou? 143 C 65t 30 136 t 77) 30 0.10 .705 
TouhamiZ8 407 5 47t 35 381 2 50f 34 0.54 .O29 
C h e G  98 ? 68t 72 77 t 55t 71 0.34 .O44 
Pooled data 137 135 0.22 .O56 
* d = the standardized difference between treatment groups, calculated as 
(8, - X,,)/SDp, where -8, = mean value for undiluted group, 
X, = mean value for diiuted/delayed group, and 
SD, = pooled SD of both groups. 
t Stool output reported as grams per day by Touhami et al and as grams per kilogram per day by other 
investigators. (No values provided for pooled data because the results were presented in different 
units.) 
TABLE 9. 
During Therapy 
Duration of Diarrhea (Hours) Following Initiation of Study in Patients Receiving Either 
, Undiluted Lactose-Containing Milk or the Same Milk at Reduced Concentration or Introduced Later 
Study Dietary Group d‘ P 
Undiluted Diluted/Delayed 
Mean 2 SD n Mean C SD n 
Conway” 68 C 44 50 64 2 54 50 
Ransome2I 63 t 44 37 59 t 48 37 
MadkouPt 60 -E. 15 30 61 C 18 30 
R e e ~ ~ ~  82 2 36 16 86 C 34 14 
Touhami% 47 t 9 35 39 2 7 34 
Chew30 92 t 50 72 92 2 44 71 
Haque3I 91 2 29 52 72 -C 34 52 
MaudgaP2 70 2 25 77 86 2 15 82 
~0x33 101 2 38 30 103 C 41 32 
Pooled data 72 C 39 437 72240 439 
Chiriboga”t 36 2 22 38 36 It 25 37 
‘ d = standardized difference between treatment groups, calculated as 
0.08 
0.09 
-0.04 
-0.11 
0.99 
O 
O 
0.60 
-0.75 
-0.06 
0.02 
.686 
.710 
.887 
,760 
<.O01 
1.000 
1 .o0 
.O03 
<.o01 
.810 
.450 
(8, - 8,,)/SD,, where 3, = mean value for undiluted group, 
X, = mean value for diluted/delayed group, and 
SD, = pooled SD of both groups. 
t Studies permitting other foods in addition to formula diets. 
all. Removal of those studies that permitted consump- 
tion of other foods did not alter this conclusion. 
Weight Gain 
Seven reports contained interpretable information 
on weight change in response to therapy (Table 10). 
In all but one case the weight gains were greater (or 
less negative) in the group that received the more con- 
centrated milk diet. The pooled data demonstrate a 
significant advantage of undiluted-milk feeding on 
body weight ( P  = .002), with an average effect size of 
0.25 SD. The magnitude of the effect was homoge- 
neous across studies ( P  = .16). 
DISCUSSION 
The appropriate use of lactose-containing, nonhu- 
man milks and infant formulas for the dietary man- 
agement of young children with acute diarrhea has 
been controversial, in part because relevant studies 
have included patients with varying severity of illness 
severity and have employed a variety of study diets 
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and research designs. Moreover, individual studies 
have often been inconclusive because of the relatively 
small numbers of patients that were enrolled. To over- 
come these difficulties with the interpretation of 
available literature, we have completed a meta- 
analysis of randomized clinical trials that fulfill spe- 
cific acceptance criteria. The advantage of this ap- 
proach is that data from multiple different trials can 
be pooled to better assess the effects of different forms 
of therapy.3439 
Limitations of This Meta-analysis 
Potential problems with the interpretation of meta- 
analyses occur when there is heterogeneity of the 
magnitude of treatment effects.%J9 For this reason, 
our conclusions were intentionally conservative 
when heterogeneity was observed. Moreover, we at- 
tempted to reanalyze the results after removing the 
study or studies responsible for heterogeneity. We 
also analyzed separate subgroups o 
by either the initial characteristics 
! 
i 
i * 
? 
JABLE 10. 
the Same Milk at Reduced Concentration or Introduced Later During Therapy 
Change in Body Weight Following Initiation of Study in Patients Receiving Either Undiluted Lactose-Containing Milk or 
- 
Study Unit of Dietary Group d t  P 
Measure' 
Undiluted Diluted/Delayed 
Mean t SD n Mean t SD n 
S~eprapto '~ g/d; d l l -d l  49 t 56 20 6 ? 56 20 0.77 .O20 
MadkouP %; rec-dl 4.8 t 1.8 30 4.3 t 1.9 30 0.27 ,300 
Dugdale= g/d; d2-dl -20 ? 250 28 -140 2 210 32 0.52 .O48 
Touhami'' %; rec-dl 2.5 t 0.6 35 2.6 5 0.5 34 -0.18 .460 
ChiribogaZ9 g; rec-dl 200 t 290 38 100 t 190 37 0.41 .O82 
Che+" %; rec-dl 0.8 t 4.7 72 0.3 2 4.4 71 0.11 .510 
~0x33 %; rec-dl 1.8 t 5.0 30 0.4 ? 3.9 32 0.31 .220 
Pooled data t 253 $ 256 0.25 .o02 
* Unit of measurement of weight change; period of observation (rec = day of recovery or discharge from study). 
t d = the standardized difference between treatment groups, calculated as 
(xu - R,,)/SD,, where 2, = mean value for undiluted group, 
$ No values provided for pooled data because the results were presented in different units. 
x, = mean value for diluted/delayed group, and 
SD = pooled SD of both groups. 
specific features of the study protocols that might 
have explained the heterogeneity of results. Natu- 
rally, this was possible only when there were a suf- 
ficient number of studies examining the outcome of 
interest. Factors that were considered as possibly in- 
fluencing the major outcomes were initial severity of 
dehydration, as defined by the authors, year in which 
the study was reported, type of milk prescribed, other 
foods offered during treatment, and age and nutri- 
tional status of the patients. Regrettably, the studies 
rarely presented data that were sufficiently disaggre- 
gated to permit exploration of the latter two factors. 
Another concern with meta-analyses is the possi- 
bility of publication bias. It is ordinarily assumed that 
clinical trials with negative results are less likely to be 
published. In this case, any publication bias would be 
likely to exaggerate the differences between whole 
milk and diluted or lactose-free milk. Although this 
possibility cannot be excluded, it is noteworthy that 
many of the studies did report seemingly negative 
results. Moreover, two nonpublished studies of suf- 
ficient quality to be considered, both with negative 
results, were also included. 
Lactose-Containing Versus Lactose-Free Feeding 
Because an earlier qualitative review discovered 
that study outcomes varied according to the diets that 
were employed? independent analyses were com- 
pleted for those studies that compared lactose-free di- 
ets with lactose-containing diets and for those that 
compared undiluted milk-based diets with the same 
milks offered at lower concentration or at a later point 
in convalescence. The results of these analyses con- 
firm that the vast majority of young children with 
acute diarrhea can safely continue to receive undi- 
luted, nonhuman milk. Nevertheless, the previously 
conducted clinical trials, taken as a whole, indicate 
that children who continue to receive lactose- 
containing milk diets during acute diarrhea are twice 
as likely to have a treatment failure as those who re- 
ceive a lactose-free diet; the absolute excess treatment 
failure rate is about 10% of patients. This difference in 
clinical outcome is probably due to the somewhat 
greater stool outputs that occurred with milk feeding. 
It is important to note, however, that adverse clinical 
outcomes were limited to that subgroup of studies 
that included patients with severe dehydration ini- 
tially, as defined by the authors, previous treatment 
failures, or underlying severe malnutrition. There 
were no clinically significant complications of con- 
tinued milk feeding in studies of non-severely dehy- 
drated children. Moreover, nearly all of the more re- 
cently completed studies, which used widely 
accepted treatment protocols for oral rehydration 
therapy and early feeding, found no adverse effects of 
continued milk consumption during diarrhea, re- 
gardless of the patients' initial hydration status. Al- 
though the duration of diarrhea may be slightly pro- 
longed in children who receive lactose-containing 
milks, the magnitude of this difference is probably of 
little clinical importance. Moreover, addition of solid 
foods to milk-containing regimens apparently elimi- 
nates the minor differences observed. Available data 
are inadequate to assess the relative effects of these 
feeding regimens on change in body weight. 
Diluted Versus Undiluted Milk 
When continued feeding with undiluted milk was 
compared with diluted or delayed reintroduction of 
milk, somewhat different conclusions emerged. As 
with the lactose-containing vs lactose-free diets, there 
was a significantly increased risk of treatment failure 
with undiluted milk when compared with diluted 
milk, but the magnitude of this difference was smaller 
and of marginal statistical significance. Again, the di- 
luted milk regimens were more likely to show supe- 
rior efficacy only when the underlying illness was 
more severe. Notably, however, the small clinical ad- 
vantage of feeding with diluted milk was offset by the 
poorer weight gains of children who received these 
regimens. Thus, the decision with regard to patient 
management may require a trade-off between the 
very small excess risk of relapsing diarrhea vs sub- 
optimal nutritional therapy. For children with rela- 
tively mild diarrhea, it would seem to be preferable 
to provide undiluted milk. 
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d The obvious critical question for clinicians and 
managers of diarrheal disease control programs is 
'whether the small number of treatment failures at- 
tributable to continued feeding of undiluted, lactose- 
containing milks merits recommending a systematic 
change in diet, with its associated cost, complexity, 
and possible adverse nutritional effects, for children 
whose preillness regimen is based exclusively or pre- 
dominantly on lactose-containing milk. Based on this 
meta-analysis, we conclude that routine dilution of 
milk and routine use of lactose-free milk formula are 
not justified, especiaIly when oral rehydration 
therapy and early feeding with solid foods (in addi- 
tion to milk) form the basic approach to the clinical 
management of diarrhea in infants and children. 
However, children with severe maln~tr i t ion~~ or with 
persistent diarrhea4* and the few children whose di- 
arrhea obviously worsens when given milk should 
probably be treated with dietary regimens that con- 
tain reduced lactose, although this should not be done 
at the expense of adequate nutrient intake. Alterna- 
tive diets that may be used when low-cost, commer- 
cially prepared, lactose-free products are not avail- 
able include cereal-milk mixtures or, possibly, 
fermented milk products. These latter possibilities 
have been reviewed previously.24 Although human 
milk contains more lactose than cow milk and many 
infant formulas, available evidence indicates that hu- 
man milk is well tolerated during diarrhea and may, 
in fact, reduce the severity42 and duration43 of illness. 
Thus, current recommendations in support of con- 
tinued breast-feeding during childhood diarrhea 
should not be affected by the results of this meta- 
analysis. 
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PSYCHIATRIC EFFECTS OF EXPOSURE TO SUICIDE AMONG THE 
FRIENDS AND ACQUAINTANCES OF ADOLESCENT SUICIDE VICTIMS 
David A. Brent, M.D., Joshua Perper, M.D., Grace Moritz, A.C.S.W., 
Christopher Allman, B.S., Amy Friend, Joy Schweers, M.Ed., Claudia Roth, 
B.S., Lisa Balach, B.S., and Kelly Harrington, B.A. 
Abstract. The friends and acquaintances (N = 58) of 10 adolescent suicide victims 
were interviewed 6 months after the death of the victims, and the rates of psychiatric 
disorders that had onset after the death were compared with the 6-month incidence 
of psychopathology in 58 demographically and psychiatrically matched unexposed 
controls. The exposed group showed higher rates of any new onset major depressive 
disorder, but the rate of incident suicide attempts was the same in both groups. The 
median onset of incident depression among the exposed group was within the first 
month after exposure, and the majority of those exposed youth with incident de- 
pression were still depressed at interview 6 months after the death. Adolescent 
friends and acquaintances of suicide victims experience considerable psychiatric 
morbidity subsequent to exposure to suicide, most consistent with pathological 
grief. J Am Acad Child Adolesc Psychiatry. 1992;31(4):629-640. Key Words: suicide, 
bereavement, depression. 
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